Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX: MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
2.400
0.00 (0.00%)
At close: Nov 20, 2024

MCRO Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,3461,6821,870--
Market Cap Growth
-28.35%-10.06%---
Enterprise Value
1,4971,8151,944--
Last Close Price
2.362.953.18--
PE Ratio
--10.59--
Forward PE
-10.0610.06--
PS Ratio
5.023.202.56--
PB Ratio
26.8117.834.04--
P/TBV Ratio
46.2625.104.55--
P/FCF Ratio
44.61-14.43--
P/OCF Ratio
28.62-13.86--
PEG Ratio
0.420.420.42--
EV/Sales Ratio
5.863.452.66--
EV/EBITDA Ratio
--8.17--
EV/EBIT Ratio
--8.30--
EV/FCF Ratio
49.63-15.00--
Debt / Equity Ratio
5.502.400.440.270.26
Debt / EBITDA Ratio
--0.830.470.35
Debt / FCF Ratio
9.12-1.582.201.64
Asset Turnover
0.340.771.021.21-
Inventory Turnover
1.451.641.642.15-
Quick Ratio
0.870.291.181.191.18
Current Ratio
1.291.082.002.312.06
Return on Equity (ROE)
-169.61%-97.85%42.36%48.77%-
Return on Assets (ROA)
-32.17%-16.72%20.53%25.81%-
Return on Capital (ROIC)
-50.29%-23.07%26.08%33.12%-
Earnings Yield
-34.00%-16.21%9.29%--
FCF Yield
2.24%-2.64%6.93%--
Dividend Yield
0.00%-3.36%--
Payout Ratio
0.00%-23.01%31.65%54.65%
Buyback Yield / Dilution
5.38%1.46%0.88%--
Total Shareholder Return
5.38%1.46%4.24%--
Source: S&P Capital IQ. Standard template. Financial Sources.